<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-GB">
	<id>https://www.sehk-wiki.org/index.php?action=history&amp;feed=atom&amp;title=Cefotaxime</id>
	<title>Cefotaxime - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.sehk-wiki.org/index.php?action=history&amp;feed=atom&amp;title=Cefotaxime"/>
	<link rel="alternate" type="text/html" href="https://www.sehk-wiki.org/index.php?title=Cefotaxime&amp;action=history"/>
	<updated>2026-05-02T08:35:39Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.0</generator>
	<entry>
		<id>https://www.sehk-wiki.org/index.php?title=Cefotaxime&amp;diff=4884&amp;oldid=prev</id>
		<title>Zeki at 00:56, 18 November 2024</title>
		<link rel="alternate" type="text/html" href="https://www.sehk-wiki.org/index.php?title=Cefotaxime&amp;diff=4884&amp;oldid=prev"/>
		<updated>2024-11-18T00:56:55Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en-GB&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 20:56, 17 November 2024&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l3&quot;&gt;Line 3:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 3:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[:Category: Antibiotics | &amp;#039;&amp;#039;&amp;#039;Oral Antibiotics&amp;#039;&amp;#039;&amp;#039;]]&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[:Category: Antibiotics | &amp;#039;&amp;#039;&amp;#039;Oral Antibiotics&amp;#039;&amp;#039;&amp;#039;]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&#039;&#039;&#039;Drug class: [[:Category: Third Generation Cephalosporin Antibiotic | Third-Generation Cephalosporin Antibiotic]]&#039;&#039;&#039;; beta-&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;lactum &lt;/del&gt;antibiotics, specifically categorized as a THIRD-generation cephalosporin.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&#039;&#039;&#039;Drug class: [[:Category: Third Generation Cephalosporin Antibiotic | Third-Generation Cephalosporin Antibiotic]]&#039;&#039;&#039;; beta-&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;lactam &lt;/ins&gt;antibiotics, specifically categorized as a THIRD-generation cephalosporin.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;Cefotaxime (CLAROFAN)&amp;#039;&amp;#039;&amp;#039;（中文：[[頭孢噻肟]]）&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;Cefotaxime (CLAROFAN)&amp;#039;&amp;#039;&amp;#039;（中文：[[頭孢噻肟]]）&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Zeki</name></author>
	</entry>
	<entry>
		<id>https://www.sehk-wiki.org/index.php?title=Cefotaxime&amp;diff=4838&amp;oldid=prev</id>
		<title>Zeki: Created page with &quot;Category: DrugsCategory: Third Generation Cephalosporin Antibiotic   &#039;&#039;&#039;Oral Antibiotics&#039;&#039;&#039;  &#039;&#039;&#039;Drug class: :Category: Third Generation C...&quot;</title>
		<link rel="alternate" type="text/html" href="https://www.sehk-wiki.org/index.php?title=Cefotaxime&amp;diff=4838&amp;oldid=prev"/>
		<updated>2024-11-11T01:55:05Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;&lt;a href=&quot;/index.php/Category:Drugs&quot; title=&quot;Category:Drugs&quot;&gt;Category: Drugs&lt;/a&gt;&lt;a href=&quot;/index.php/Category:Third_Generation_Cephalosporin_Antibiotic&quot; title=&quot;Category:Third Generation Cephalosporin Antibiotic&quot;&gt;Category: Third Generation Cephalosporin Antibiotic&lt;/a&gt;  &lt;a href=&quot;/index.php/Category:Antibiotics&quot; title=&quot;Category:Antibiotics&quot;&gt; &amp;#039;&amp;#039;&amp;#039;Oral Antibiotics&amp;#039;&amp;#039;&amp;#039;&lt;/a&gt;  &amp;#039;&amp;#039;&amp;#039;Drug class: :Category: Third Generation C...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[Category: Drugs]][[Category: Third Generation Cephalosporin Antibiotic]]&lt;br /&gt;
&lt;br /&gt;
[[:Category: Antibiotics | &amp;#039;&amp;#039;&amp;#039;Oral Antibiotics&amp;#039;&amp;#039;&amp;#039;]]&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Drug class: [[:Category: Third Generation Cephalosporin Antibiotic | Third-Generation Cephalosporin Antibiotic]]&amp;#039;&amp;#039;&amp;#039;; beta-lactum antibiotics, specifically categorized as a THIRD-generation cephalosporin.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Cefotaxime (CLAROFAN)&amp;#039;&amp;#039;&amp;#039;（中文：[[頭孢噻肟]]）&lt;br /&gt;
==Common Strengths==&lt;br /&gt;
Commonly available strengths of cefotaxime include:&lt;br /&gt;
*500 mg&lt;br /&gt;
*1 g&lt;br /&gt;
*2 g&lt;br /&gt;
&lt;br /&gt;
==Trade Names==&lt;br /&gt;
The primary trade name for cefotaxime is Claforan.&lt;br /&gt;
&lt;br /&gt;
==Drug Usage==&lt;br /&gt;
Cefotaxime is indicated for:&lt;br /&gt;
*Joint infections&lt;br /&gt;
*Pelvic inflammatory disease&lt;br /&gt;
*Meningitis&lt;br /&gt;
*Pneumonia&lt;br /&gt;
*Urinary tract infections&lt;br /&gt;
*Sepsis&lt;br /&gt;
*Gonorrhea&lt;br /&gt;
*Cellulitis&lt;br /&gt;
&lt;br /&gt;
==Mechanism of Action==&lt;br /&gt;
Cefotaxime works by inhibiting bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs), blocking the transpeptidation step in peptidoglycan synthesis, leading to bacterial cell lysis and death.&lt;br /&gt;
&lt;br /&gt;
==Route of Administration==&lt;br /&gt;
Cefotaxime is administered via intravenous (IV) or intramuscular (IM) injection.&lt;br /&gt;
&lt;br /&gt;
==Dosages==&lt;br /&gt;
*Uncomplicated infections: 1 g IM or IV every 12 hours.&lt;br /&gt;
*Moderate to severe infections: 1 to 2 g IM or IV every 8 hours.&lt;br /&gt;
*Life-threatening infections: 2 g IV every 4 hours.&lt;br /&gt;
*Renal Dose Adjustments:&lt;br /&gt;
**For patients with creatinine clearance (CrCl) less than 20 mL/min, the dose should be reduced by 50%.&lt;br /&gt;
&lt;br /&gt;
==Side Effects==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
!style=&amp;quot;text-align: left&amp;quot;| Frequency&lt;br /&gt;
!Adverse reactions&lt;br /&gt;
|-&lt;br /&gt;
| rowspan=&amp;quot;3&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Common Side Effects&lt;br /&gt;
| Nausea&lt;br /&gt;
|-&lt;br /&gt;
| Diarrhea&lt;br /&gt;
|-&lt;br /&gt;
| Injection site reactions (pain, redness, swelling)&lt;br /&gt;
|-&lt;br /&gt;
| rowspan=&amp;quot;4&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Serious Side Effects&lt;br /&gt;
| Severe allergic reactions (anaphylaxis)&lt;br /&gt;
|-&lt;br /&gt;
| Clostridium difficile-associated diarrhea&lt;br /&gt;
|-&lt;br /&gt;
| Hemolytic anemia&lt;br /&gt;
|-&lt;br /&gt;
| Nephrotoxicity, especially when combined with other nephrotoxic agents&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Pharmacokinetics==&lt;br /&gt;
*The onset of action for cefotaxime typically begins within 30 minutes after IM injection or immediately following IV administration.&lt;br /&gt;
*The duration of action is influenced by the half-life (approximately 1 hour); due to its relatively short half-life, cefotaxime is often administered every 6 to 12 hours depending on the infection being treated and patient response. For example:&lt;br /&gt;
**In uncomplicated infections, treatment may last around 7 days.&lt;br /&gt;
**In more complicated cases, such as meningitis or severe infections, therapy could extend to 10-14 days.&lt;br /&gt;
&lt;br /&gt;
In summary, cefotaxime has a quick onset of action and a short duration of effect, necessitating frequent dosing to maintain effective serum concentrations for therapeutic efficacy against bacterial infections.&lt;br /&gt;
&lt;br /&gt;
==Drug Precautions==&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Pregnancy&lt;br /&gt;
&lt;br /&gt;
Category B; generally considered safe, but benefits must be weighed against risks.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Breastfeeding&lt;br /&gt;
&lt;br /&gt;
Excreted in breast milk; caution is advised.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Children and Elderly&lt;br /&gt;
&lt;br /&gt;
Generally safe, but dosage adjustments may be necessary for renal function.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Monitoring Items&lt;br /&gt;
&lt;br /&gt;
Renal function, liver enzymes, and signs of allergic reactions should be monitored during treatment.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Drug Interactions&lt;br /&gt;
&lt;br /&gt;
Notable interactions include:&lt;br /&gt;
*Increased risk of bleeding: When used with anticoagulants like warfarin, careful monitoring of coagulation parameters is necessary.&lt;br /&gt;
*Increased nephrotoxicity with aminoglycosides.&lt;br /&gt;
*Hormonal contraceptives: Cefotaxime may reduce the effectiveness of hormonal contraceptives, necessitating alternative contraceptive methods during treatment.&lt;br /&gt;
*Probenecid can increase cefotaxime levels.&lt;br /&gt;
&lt;br /&gt;
==FAQ==&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;How Should I Take the cefaclor?&lt;br /&gt;
&lt;br /&gt;
Cefotaxime is typically administered by injection.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;What Should I Avoid While Taking?&lt;br /&gt;
&lt;br /&gt;
Avoid combining cefotaxime with other nephrotoxic drugs unless monitored closely.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;What Happens if I Miss a Dose?&lt;br /&gt;
&lt;br /&gt;
If a dose is missed, take it as soon as remembered. If it is almost time for the next dose, skip the missed dose and continue with the regular schedule.&lt;/div&gt;</summary>
		<author><name>Zeki</name></author>
	</entry>
</feed>